Expression of Phenotypic Astrocyte Marker Is Increased in a Transgenic Mouse Model of Alzheimer’s Disease versus Age-Matched Controls: A Presymptomatic Stage Study

<div>Immunofluorescence of GFAP/TSPO colocalization in hippocampal subregions of WT and APPswe/PS1dE9 mice at 3 months. Confocal staining of DAPI for nuclei (blue), GFAP for astrocytes (green), and TSPO (red) in DG (a) and CA1-2 (b) in WT (upper) and APPswe/PS1dE9 (lower) mice. A white square represents a magnified region of interest. Scale bar: 50 <i>µ</i>m.</div>

International Journal of Alzheimer’s Disease

fig4

Figure 4

Figure 4: Expression of Phenotypic Astrocyte Marker Is Increased in a Transgenic Mouse Model of Alzheimer’s Disease versus Age-Matched Controls: A Presymptomatic Stage Study 

Figure 4 | Expression of Phenotypic Astrocyte Marker Is Increased in a Transgenic Mouse Model of Alzheimer’s Disease versus Age-Matched Controls: A Presymptomatic Stage Study 